Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Veronika Müller; Gabriella Gálffy; Noemi Eszes; György Losonczy; Andrea Bizzi; Gabriele Nicolini; Henry Chrystyn; Lilla Tamási

doi:10.1186/1471-2466-11-40

Download references

Asthma control in patients receiving inhaled corticosteroid and long-acting beta₂-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Veronika Müller^†, Gabriella Gálffy^†, Noemi Eszes, György Losonczy, Andrea Bizzi, Gabriele Nicolini, Henry Chrystyn and Lilla Tamási^*

* Corresponding author: Lilla Tamási tamasi@pulm.sote.hu
† Equal contributors

BMC Pulmonary Medicine 2011, 11:40 doi:10.1186/1471-2466-11-40

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

BMC Pulmonary Medicine

Viewing options

Associated material

Tools

Share this article

Download references

Asthma control in patients receiving inhaled corticosteroid and long-acting beta₂-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

BMC Pulmonary Medicine

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Download references

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Asthma control in patients receiving inhaled corticosteroid and long-acting beta₂-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation